4//SEC Filing
YVER ANTOINE 4
Accession 0000899243-22-030302
CIK 0001847903other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 5:00 PM ET
Size
5.9 KB
Accession
0000899243-22-030302
Insider Transaction Report
Form 4
YVER ANTOINE
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2022-09-01$4.41/sh−10,423$45,987→ 789,751 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 represent the number of shares sold by the Reporting Person for the purpose of covering tax withholding obligations in connection with the vesting of the restricted shares pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 17, 2021, as amended, and does not represent a discretionary trade by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.355 to $4.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861878
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 5:00 PM ET
- Size
- 5.9 KB